IP Library › Patent Application 11446075
Patent Application
App. No. 11/446,075

Heterocyclic fused imidazolone, dioxolone, imidazolethione and dioxolethione monomers

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/446,075
Abstract

A method of making a compound of the formula shown below is disclosed: wherein Z is Se or S; Y is NH or O; X is O or S and W and W′ are independently selected from the group consisting of hydrogen, —C═ONH 2 , —C═ONHR′, —C═ONR′R′, —C≡N, and R′ is C 1-6 alkyl and the resultant monomer compounds. The method includes contacting a 3,4-disubstituted thiophene or selenophene or disubstituted thiophene or selenophene derivatives with a carbonyl or thiocarbonyl containing compound selected from the group consisting of ureas, thioureas, carbonate esters, thionocarbonates, thiocarbonate esters, or orthocarbonates. The monomer compounds are suitable for forming polymers for use in a wide range of electronic applications.

Claims (29)

1 . A method for making a monomer for forming an electrically conductive polymer comprising:

providing a first reactant comprising at least one compound selected from the group consisting of 3,4-diaminothiophene, 3,4-dihydroxythiophene, 3,4-diaminoselenophene, 3,4-dihydroxyselenophene, derivatives of 3,4-diaminothiophene, derivatives of 3,4-dihydroxythiophene, derivatives of 3,4-diaminoselenophene, derivatives of 3,4-dihydroxyselenophene, and combinations thereof;

providing a second reactant comprising at least one compound selected from the group consisting of a urea containing compound, a carbonate ester containing compound, an orthoester containing compound, a thiourea containing compound, a thionocarbonate containing compound and combinations thereof;

contacting the first reactant compound and second reactant compound to form a reaction mixture;

heating the reaction mixture to a temperature sufficient to produce a monomer comprising the following formula:

wherein Z comprises Se or S; Y comprises NH or O; X comprises O or S and W and W′ comprise at least one member independently selected from the group consisting of hydrogen, —CO 2 R′, —C═ONR′R′, and —C≡N; and R′ is H or C 1-6 alkyl.

2 . The method of claim 1 , wherein the second reactant compound comprises at least one urea compound selected from the group consisting of carbonyldiimidazole, carbonyldi(1,2,4-triazole) and combinations thereof.

3 . The method of claim 1 , wherein the second reactant compound comprises at least one carbonate ester compound selected from the group consisting of dimethyl carbonate, diethyl carbonate, ethylene carbonate, propylene carbonate and combinations thereof.

4 . The method of claim 1 , wherein the second reactant compound comprises at least one orthocarbonate compound selected from the group consisting of tetramethyl orthocarbonate, tetraethyl orthocarbonate, tetrapropyl orthocarbonate and combinations thereof.

5 . The method of claim 1 , wherein the second reactant compound comprises at least one thiourea containing compound is selected from the group consisting of thiourea, N,N′-dimethylthiourea, 1,1′-thiocarbonyldiimidazole, and combinations thereof.

6 . The method of claim 1 , wherein the second reactant compound comprises at least one thionocarbonate containing compound selected from the group consisting of di-2-pyridiyl thionocarbonate, di-4-pyridyl thionocarbonate and combinations thereof.

7 . The method of claim 1 , wherein the heating step includes heating to a temperature from about 80° C. and about 175° C.

8 . The method of claim 7 , wherein the heating step includes heating to a temperature from about 90° C. and about 125° C.

9 . The method of claim 1 , wherein the contacting is performed in the presence of at least one solvent.

10 . The method of claim 9 , wherein the solvent comprises at least one member selected from the group consisting of 1,3-dimethyl-2-imidazolidinone, 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone, ethylene glycol, propylene glycol, 1,2-dimethoxyethane, tetrahydrofuran, and combinations thereof.

11 . The method of claim 1 , further comprising providing a precursor of the first reactant compound and a base material to convert the first reactant compound precursor into the first reactant compound.

12 . The method claim 11 , wherein the first reactant compound precursor comprises at least one member selected from the group consisting of 3,4-diaminothiophene dihydrochloride or 3,4-diaminoselenophene dihydrochloride.

13 . The method of claim 12 , wherein the base material comprises at least one member selected from the group consisting of triethylamine, pyridine, 2-(dimethylamino)pyridine, 4-(dimethylamino)pyridine, polymer-bound 4-(dimethylamino)pyridine, and N,N-diisopropylethylamine, and inorganic bases such as sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, sodium hydroxide, potassium hydroxide and combinations thereof.

14 . The method of claim 1 , wherein the method further comprises a step of replacing one or more of the W group and W′ group with hydrogen after the heating step.

15 . A monomer compound comprising the following formula:

wherein Y comprises NH or O; and X comprises O or S.

16 . The monomer of claim 14 , wherein the monomer comprises at least one member selected from the group consisting of 1H-selenolo[3,4-d]imidazol-2(3H)-one, selenolo[3,4-d]-1,3-dioxolan-2-one, 1H-selenolo[3,4-d]imidazol-2(3H)-thione, and selenolo[3,4-d]-1,3-dioxolan-2-thione.

17 . A monomer compound comprising the following formula:

wherein X is S or O.

18 . The monomer of claim 14 , wherein the monomer comprises thieno[3,4-d]-1,3-dioxolan-2-one or thieno[3,4-d]-1,3-dioxolan-2-thione.

19 . A composition comprising at least one monomer of claim 18 and at least one catalyst.

20 . A monomer compound derivative comprising the following formula:

wherein Z comprises S or Se; Y comprises NH or O; X comprises O or S; W and W′ comprises at least one member independently selected from the group consisting of halogen atoms, MgCl, MgBr, MgI, ZnCl, ZnBr, ZnI, Sn(R′) 3 , boronic acid, boronic ester, —CH═CHR″, —OC 1-6 alkyl, —COOC 1-6 alkyl, —S—COR′″, —COR′″, —C≡CH and polymerizable aromatic groups; R′ is C 1-6 alkyl or —OC 1-6 alkyl; and R″ and R′″ are H or C 1-6 alkyl.

21 . The monomer compound derivative according to claim 20 , wherein the polymerizable aromatic groups comprise at least one member selected from the group consisting of phenyl, naphthalene, pyrrole, dithiophene, thienothiophene, and thiophene.

Assignments (5)
NUNC PRO TUNC ASSIGNMENT Recorded Apr 5, 2024
From: CSA MEDICAL, INC.
To: EVERGREEN VENTURES LTD; CHV III, L.P.; SV LIFE SCIENCES FUND V.I.P.; SV LIFE SCIENCES FUND V. STRATEGIC PARTNERS, L.P.; INTERSOUTH PARTNERS VII, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V-A, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V-C, L.P.; BHCM CSA MEDICAL, L.L.C.; ALFRED M. RANKIN, JR. TRUST; BENMIKE INVESTMENT CO. LLC; CHARLES G. BROWN, INC.; CLAIBORNE R. RANKIN REVOCABLE TRUST U/A/D 6/22/71; BROWN, DAVID P., MR.; INKLEY, E. DALE; COWELL, ENSIGN; KRONEBERGER,, G. BRIAN, JR.; LINCOLN, G. RUSSELL; G. RUSSELL LINCOLN REVOCABLE TRUST DTD 10/31/2007; GUIDE MEDICAL VENTURES, L.L.C.; H&B INVESTMENT PARTNERSHIP; MAHONEY, JAMES J., JR.; DAVIDSON, MARC S.; DYER, MARK V.; MEDTECH INVESTMENTS, LLC; ELLIS, MICHAEL A.; MWK TRUST, MIRIAM WINDER-KELLY TTE; SMITH, NATHANIEL T.; MARY T. VON HERRMANN FAMILY TRUST; SCHWARZ, RICHARD T.; PECK, STEVEN E.; SCHAEFER, STEVEN E.; SYCAMORE FUND 1, LLC; SYMARK LLC; TIMOTHY T. WEGLICKI RESTATED RECOVABLE TRUST U/A DTD 9-13-2022 AS AMENDED AND RESTATED DURING LIFETIME OF TIMOTHY T WEGLICKI; MELITA, TOM; VICTORIE G. RANKIN TRUST; WILLIAM E. CONWAY UTA DATED 12/12/80 AS AMENDED
Reel/Frame 067025/0210 →
SECURITY INTEREST Recorded Jan 25, 2024
From: CSA MEDICAL, INC.
To: SYCAMORE FUND 1, LLC; SYMARK LLC; CHV III, L.P.; SV LIFE SCIENCES FUND V, STRATEGIC PARTNERS, L.P.; SV LIFE SCIENCES FUND V, L.P.; INTERSOUTH PARTNERS VII, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V-A, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V-C, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V, L.P.; BHCM CSA MEDICAL, LLC; ALFRED M. RANKIN, JR. TRUST; BENMIKE INVESTMENT CO. LLC; CHARLES G. BROWN, INC.; CLAIBORNE R. RANKIN REVOCABLE TRUST U/A/D 6/22/71; BROWN, DAVID P.; INKLEY, E. DALE; COWELL, ENSIGN; EVERGREEN VENTURES LTD; KRONEBERGER, G. BRIAN, JR.; G. RUSSELL LINCOLN REVOCABLE TRUST DTD 10/31/2007; LINCOLN, G. RUSSELL; GUIDE MEDICAL VENTURES, LLC; H&B INVESTMENT PARTNERSHIP; MAHONEY, JAMES J., JR.; DAVIDSON, MARC S.; DYER, MARK V.; MEDTECH INVESTMENTS, LLC; ELLIS, MICHAEL A.; MWK TRUST, MIRIAM WINDER-KELLY TTE; SMITH, NATHANIEL T.; MARY T. VON HERRMANN FAMILY TRUST; SCHWARTZ, RICHARD T.; PECK, STEVEN E.; SCHAEFER, STEVEN E.; TIMOTHY T WEGLICKI RESTATED REVOCABLE TRUST U/A DTD 9-13- 2022 AS AMENDED AND RESTATED DURING LIFETIME OF TIMOTHY T WEGLICKI; MELITA, TOM; VICTOIRE G. RANKIN TRUST; WILLIAM E. CONWAY UTA DATED 12/12/80 AS AMENDED
Reel/Frame 066242/0249 →
SECURITY INTEREST Recorded Sep 20, 2023
From: CSA MEDICAL, INC.
To: CHV III, L.P.; SV LIFE SCIENCES FUND V, STRATEGIC PARTNERS, L.P.; SV LIFE SCIENCES FUND V, L.P.; INTERSOUTH PARTNERS VII, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V-A, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V-C, L.P.; FIRST ANALYSIS PRIVATE EQUITY FUND V, L.P.; BHCM CSA MEDICAL, LLC; ALFRED M. RANKIN, JR. TRUST; BENMIKE INVESTMENT CO. LLC; CHARLES G. BROWN, INC.; CLAIBORNE R. RANKIN REVOCABLE TRUST U/A/D 6/22/71; BROWN, DAVID P.; INKLEY, E. DALE; COWELL, ENSIGN; EVERGREEN VENTURES LTD; KRONEBERGER, G. BRIAN, JR.; G. RUSSELL LINCOLN REVOCABLE TRUST DTD 10/31/2007; LINCOLN, G. RUSSELL; GUIDE MEDICAL VENTURES, LLC; H&B INVESTMENT PARTNERSHIP; MAHONEY, JAMES J., JR.; DAVIDSON, MARC S.; MEDTECH INVESTMENTS, LLC; ELLIS, MICHAEL A.; MWK TRUST, MIRIAM WINDER-KELLY TTE; SMITH, NATHANIEL T.; MARY T. VON HERRMANN FAMILY TRUST; SCHWARZ, RICHARD T.; SCHAEFER, STEVEN E.; PECK, STEVEN E.; SYCAMORE FUND 1, LLC; SYMARK LLC; WEGLICKI, TIMOTHY T.; MELITA, TOM; VICTOIRE G. RANKIN TRUST; WILLIAM E. CONWAY UTA DATED 12/12/80 AS AMENDED; DYER, MARK V.
Reel/Frame 064963/0228 →
SECURITY INTEREST Recorded Dec 16, 2022
From: CSA MEDICAL, INC.
To: CHV III, L.P.; SV LIFE SCIENCES FUND V, L.P.; SV LIFE SCIENCES FUND V, STRATEGIC PARTNERS, L.P.; INTERSOUTH PARTNERS VII, L.P.; MATHERS ASSOCIATES; DISRUPTIVE INNOVATION FUND, LP; BHCM CSA MEDICAL, LLC; ALFRED M. RANKIN, JR. TRUST; BENMIKE INVESTMENT CO. LLC; CHARLES G. BROWN, INC.; CLAIBORNE R. RANKIN REVOCABLE TRUST U/A/D 6/22/71; BROWN, DAVID P; INKLEY, E. DALE; COWELL, ENSIGN; EVERGREEN VENTURES LTD; KRONEBERGER, G. BRIAN, JR.; LINCOLN, G. RUSSELL; G. RUSSELL LINCOLN REVOCABLE TRUST DTD 10/31/2007; GUIDE MEDICAL VENTURES, LLC; H&B INVESTMENT PARTNERSHIP; MAHONEY, JAMES J, JR.; DAVIDSON, MARC S; DYER, MARK V.; MEDTECH INVESTMENTS, LLC; ELLIS, MICHAEL A; MWK TRUST, MIRIAM WINDER-KELLY TTE; SMITH, NATHANIEL; NATIONAL FINANCIAL SERVICES/ FIDELITY INVESTMENTS CUSTODIAN FBO STEVEN E. SCHAEFER IRA; HERMANN, TIM VON; SCHWARZ, RICHARD T; PECK, STEVEN E.; SCHAEFER, STEVEN E.; SYCAMORE FUND 1, LLC; SYMARK LLC; WEGLICKI, TIMOTHY T.; MELITA, TOM; VICTOIRE G. RANKIN TRUST; WILLIAM E. CONWAY UTA DATED 12/12/80 AS AMENDED
Reel/Frame 062132/0359 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2006
From: ZAHN, STEFFEN; FORD, MICHAEL EDWARD
To: AIR PRODUCTS AND CHEMICALS, INC.
Reel/Frame 017819/0697 →